0.37 CNY
176.12 M CNY
657.11 M CNY
About HUBEI BIOCAUSE HEI
Sector
CEO
Qun Liang
Headquarters
Jingmen
Website
Founded
1995
ISIN
CNE100005782
FIGI
BBG00XVCGM37
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the research and development, production and sales of pharmaceutical raw materials and preparation products. The company was founded on December 29, 1995 and is headquartered in Jingmen, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 301211 is 21.07 CNY — it has decreased by −1.77% in the past 24 hours. Watch HUBEI BIOCAUSE HEI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUBEI BIOCAUSE HEI stocks are traded under the ticker 301211.
301211 stock has risen by 11.60% compared to the previous week, the month change is a 9.63% rise, over the last year HUBEI BIOCAUSE HEI has showed a −2.00% decrease.
301211 reached its all-time high on Dec 16, 2022 with the price of 46.87 CNY, and its all-time low was 13.29 CNY and was reached on Oct 11, 2022. View more price dynamics on 301211 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
301211 stock is 7.84% volatile and has beta coefficient of 1.27. Track HUBEI BIOCAUSE HEI stock price on the chart and check out the list of the most volatile stocks — is HUBEI BIOCAUSE HEI there?
Today HUBEI BIOCAUSE HEI has the market capitalization of 6.18 B, it has increased by 10.55% over the last week.
Yes, you can track HUBEI BIOCAUSE HEI financials in yearly and quarterly reports right on TradingView.
301211 net income for the last quarter is 6.17 M CNY, while the quarter before that showed 31.11 M CNY of net income which accounts for −80.18% change. Track more HUBEI BIOCAUSE HEI financial stats to get the full picture.
Yes, 301211 dividends are paid annually. The last dividend per share was 0.48 CNY. As of today, Dividend Yield (TTM)% is 2.24%. Tracking HUBEI BIOCAUSE HEI dividends might help you take more informed decisions.
HUBEI BIOCAUSE HEI dividend yield was 2.21% in 2023, and payout ratio reached 78.50%. The year before the numbers were 0.96% and 63.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 1.01 K employees. See our rating of the largest employees — is HUBEI BIOCAUSE HEI on this list?
Like other stocks, 301211 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUBEI BIOCAUSE HEI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUBEI BIOCAUSE HEI technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUBEI BIOCAUSE HEI stock shows the buy signal. See more of HUBEI BIOCAUSE HEI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.